Abstract
The kinetics of trypsin proteolysis of the fusion protein (FP) containing human proinsulin was studied by a set of analytical micromethods. These were the microcolumn reversed-phase HPLC and the qualitative identification by MALDI-TOF mass spectrometry and amino acid sequencing. The first stage of the proteolysis was shown to be the cleavage of FP into the leader fragment and proinsulin. The subsequent splitting off ofC-peptide from proinsulin results in the formation of ArgB31-ArgB32-insulin. The effect of temperature on the formation of de-ThrB30-insulin, a by-product, was also studied. The structure of FP was confirmed by the peptide mapping technique, and the leader fragment was shown to contain noN-terminal Met residue.
Similar content being viewed by others
Abbreviations
- FP:
-
fusion protein containing the sequence of human proinsulin in its composition
- rpHPLC:
-
reversed-phase HPLC
- RHI:
-
recombinant human insulin
References
Sergeev, N.V., Nazimov, I.V., Gavrikov, V.G., and Miroshnikov, A.I.,Bioorg. Khim., 2000, vol. 26, pp. 41–50.
Brange, J.,Galenics of Insulin, Berlin: Springer, 1987, pp. 1–5.
Nilsson, J., Johansson, P., Samuelson, E., Stahl, S., and Uhlen, M.,J. Biotechnol., 1996, vol. 48, pp. 241–250.
Klyushnichenko, V.E., Yakimov, S.A., Nazimov, I.V., Arutyunyan, A.M., Ivanov, A.E., Maltsev, K.V., and Wulfson, A.N.,J. Chromatogr., B: Biomed. Appl., 1994, vol. 662, pp. 363–369.
Kang, Y. and Yoon, J.W.,J. Biotechnol., 1994, vol. 36, pp. 45–54.
Howard, W., Davidson, J., and Hutton, C.,J. Biochem., 1987, vol. 245, pp. 575–582.
Jonasson, P., Nilsson, J., Samuelson, E., Moks, T., Stahl, S., and Uhlen, M.,Eur. J. Biochem., 1988, vol. 236, pp. 656–661.
Korobko, V.G., Boldyreva, E.F., Shingarova, L.N., Miroshnikov, A.I., Gavrikov, V.G., Stepanov, A.V., and Kalinin, Yu.T., RF Patent 99 109 523/13, 1999,Byull. Izobret., 1999, no. 36.
Mirgorodskaya, O.A., Kazanina, G.A., Mirgorodskaya, E.P., Shevchenko, A.A., Mal’tsev, K.V., Miroshnikov, A.I., and Roipstorff, P.,Bioorg. Khim., 1997, vol. 23, pp. 91–97.
United States Pharmacopoeia, 23, Second Supplement, Insulin Human, 1984, pp. 2637–2645.
British Pharmacopoeia, 1988, London: H.M. Stationary Office, 1988, pp. 312–313.
Health, W.F., Belagaje, R.M., Brooke, G.S., Chance, R.E., Hoffmann, J.A., Long, H.B., Reams, S.G., Roundtree, C., Shaw, W.N., Slicker, L.J., Sundell, K.L., and DiMarchi, R.D.,J. Biol. Chem., 1992, vol. 267, pp. 419–425.
Author information
Authors and Affiliations
Corresponding author
Additional information
For communication I, see [1].
Rights and permissions
About this article
Cite this article
Sergeev, N.V., Glukhova, N.S., Nazimov, I.V. et al. Analytical biotechnology of recombinant peptides and proteins: II. A confirmation of the primary structure of fusion protein containing human proinsulin and optimization of its proteolysis by trypsin. Russ J Bioorg Chem 26, 461–465 (2000). https://doi.org/10.1007/BF02758616
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02758616